After one year attacking vaccine efforts and promoting hydroxychloroquine, Bolsonaro makes a TV statement lying about his goverment actions
President changes tone on the day that Brazil registers more than 3,000 deaths by Covid and declares 2021 year of the vaccine (Source: Reuters: Health)
Source: Reuters: Health - March 24, 2021 Category: Consumer Health News Source Type: news
Efficacy and safety outcomes of proposed randomized controlled trials investigating hydroxychloroquine and chloroquine during the early stages of the COVID19 pandemic, BJCP
Analysis found that the 51 registered RCTs investigating hydroxychloroquine or chloroquine during the early stages of the COVID ‐19 pandemic included heterogeneous and insufficient approaches to measure efficacy/effectiveness and safety relevant to patients and clinical practice. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 24, 2021 Category: Consumer Health News Source Type: news
The Quinism Foundation Encourages Those Injured by Hydroxychloroquine...
The Foundation has Written to Newly Confirmed Secretary of Health and Human Services, Xavier Becerra, Encouraging Liberal Consideration of Claims under the Countermeasures Injury Compensation Program(PRWeb March 19, 2021)Read the full story at https://www.prweb.com/releases/the_quinism_foundation_encourages_those_injured_by_hydroxychloroquine_and_related_quinoline_antimalarial_drugs_to_file_timely_claims_for_government_compensation/prweb17811259.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 19, 2021 Category: Pharmaceuticals Source Type: news
Cochrane Library Editorial - Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID-19
During the past 12 months chloroquine and hydroxychloroquine have been touted as cures for COVID-19 and introduced into Covid-19 treatment protocols. This has led to increases in demand, leaving some rheumatoid arthritis and lupus patients deprived of effective treatments.A newly publishedCochrane Library Editorial explores the story of the assessment of chloroquine and hydroxychloroquine efficacy and the lessons learnt. This Editorial publishes alongside the recently published review published in the Cochrane Library that concludes that hydroxychloroquine has no clinical benefit in treating COVID-19 in hospit...
Source: Cochrane News and Events - March 9, 2021 Category: Information Technology Authors: Muriah Umoquit Source Type: news
Chloroquine or hydroxychloroquine for prevention and treatment of COVID19, Cochrane Database of Systematic Reviews
Review (12 RCTs; n= 8569) found hydroxychloroquine has minimal effect on risk of mortality, no effect on progression to mechanical ventilation, and is associated with triple the number of adverse events vs placebo, therefore no further treatment trials should be carried out. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 9, 2021 Category: Consumer Health News Source Type: news
The end of hydroxychloroquine as a treatment for COVID-19
(University of Washington School of Medicine/UW Medicine) A year ago, infectious disease doctor Christine Johnston was leading a study on the use of hydroxychloroquine for the treatment of people with COVID-19. A year later, her team published results that showed the drug -- once a political football -- had no effect. Johnston talks about lessons learned under the world spotlight. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 9, 2021 Category: Infectious Diseases Source Type: news
WHO Recommends Against Hydroxychloroquine To Prevent Covid-19, Oklahoma Is Stuck With Piles Of It
Oklahoma is apparently trying to negotiate a return of 1.2 million hydroxychloroquine pills that the state purchased last year for around $2 million. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 6, 2021 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news
WHO Advises Against Hydroxychloroquine to Prevent COVID-19 WHO Advises Against Hydroxychloroquine to Prevent COVID-19
The recommendations are based on evidence from six randomised controlled trials involving over 6,000 participants with and without known exposure to a person with COVID-19 infection.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 4, 2021 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news
Societies Issue Joint Statement on Safe Use of HCQ Societies Issue Joint Statement on Safe Use of HCQ
Hydroxychloroquine can be used safely and effectively with attention to dosing, risk factors, and screening, but communication among physicians, patients, and eye care specialists is key.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 3, 2021 Category: Dermatology Tags: Infectious Diseases News Source Type: news
WHO panel issues strong advice against hydroxychloroquine for COVID-19
The drug hydroxychloroquine, once touted by former U.S. president Donald Trump as a pandemic "game-changer," should not be used to prevent COVID-19 and has no meaningful effect on patients already infected, a World Health Organization expert panel said on Tuesday. (Source: CBC | Health)
Source: CBC | Health - March 2, 2021 Category: Consumer Health News Tags: News/World Source Type: news
WHO panel: Hydroxychloroquine should not be used to prevent COVID-19
The anti-inflammatory drug hydroxychloroquine should not be used to prevent COVID-19, according to a new recommendation from the World... (Source: Reuters: Health)
Source: Reuters: Health - March 1, 2021 Category: Consumer Health News Source Type: news
WHO expert panel strongly advises against use of hydroxychloroquine to prevent covid-19
(BMJ) The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline Development Group (GDG) panel of international experts inThe BMJ today. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 1, 2021 Category: International Medicine & Public Health Source Type: news
Is chloroquine or hydroxychloroquine useful in treating people with COVID-19, or in preventing infection in people who have been exposed to the virus?
COVID-19 is an infectious respiratory disease caused by a coronavirus called SARS-CoV-2. If the infection becomes severe, people may need intensive care and support in hospital, including mechanical ventilation.Drugs used for other diseases were tried out in COVID-19, and this included chloroquine, used for malaria; and hydroxychloroquine used for rheumatic diseases, such as rheumatoid arthritis or systemic lupus erythematosus. The authors sought evidence of the effects of these drugs in treating people ill with the disease; in preventing the disease in people at risk of getting the disease, such as health workers; and peo...
Source: Cochrane News and Events - February 10, 2021 Category: Information Technology Authors: Katie Abbotts Source Type: news
NIH Director Francis Collins Is Fighting This Coronavirus While Preparing for the Next One
In May 2020, Dr. Francis Collins, the longtime head of the National Institutes of Health (NIH), was called to the White House to meet with Jared Kushner, the then President’s son-in-law and adviser, and Dr. Deborah Birx, the head of the White House Coronavirus Task Force. A few weeks earlier, Congress had given the NIH $1.5 billion to try to speed up the process of developing new diagnostic tests for COVID-19, and the White House, which was dubious about increasing the rate of testing, wanted to know more about what the NIH was doing.
Collins is technically the boss of Dr. Anthony Fauci, but during the pandemic he ha...
Source: TIME: Health - February 4, 2021 Category: Consumer Health News Authors: Belinda Luscombe Tags: Uncategorized COVID-19 feature Magazine Source Type: news
How the Search for Covid-19 Treatments Faltered While Vaccines Sped Ahead
Vaccine development exceeded everyone ’s expectations. But the next few months will still bring many sick people — and doctors have woefully few drugs with which to treat them. (Source: NYT Health)
Source: NYT Health - January 30, 2021 Category: Consumer Health News Authors: Carl Zimmer Tags: Clinical Trials Coronavirus (2019-nCoV) Hydroxychloroquine (Drug) Drugs (Pharmaceuticals) Research your-feed-healthcare Remdesivir (Drug) Source Type: news
